Thermo Fisher Scientific (TMO) Total Non-Current Liabilities (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Total Non-Current Liabilities for 18 consecutive years, with $56.9 billion the latest figure, recorded in Q1 2026.

• Total Non-Current Liabilities for Q1 2026 came in at $56.9 billion, up 24.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $56.9 billion (up 24.53% YoY), and the FY2025 annual result was $52.7 billion, up 20.27% from the prior year.
• Total Non-Current Liabilities was $56.9 billion for Q1 2026 at Thermo Fisher Scientific, up from $52.7 billion in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $56.9 billion in Q1 2026 and troughed at $42.5 billion in Q4 2022.
• Average Total Non-Current Liabilities over 5 years is $47.4 billion, with a median of $47.0 billion recorded in 2024.
• Year-over-year, Total Non-Current Liabilities surged 71.08% in 2022 and slipped 7.56% in 2024.
• Over 5 years, Total Non-Current Liabilities stood at $48.9 billion in 2022, then retreated by 3.12% to $47.4 billion in 2023, then retreated by 7.56% to $43.8 billion in 2024, then advanced by 20.27% to $52.7 billion in 2025, then gained by 8.11% to $56.9 billion in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $56.9 billion in Q1 2026, $52.7 billion in Q4 2025, and $47.7 billion in Q3 2025.